01—Abstract
Summary
Summary of the 10-K filed February 13, 2024. Cited figures are marked; the original filing is the authoritative source.
Leidos Holdings, Inc. ("Leidos") reported fiscal 2023 revenues of $15.44 billiona, up $1.04 billion (7%) from $14.40 billion in fiscal 2022, driven by program wins, higher volumes and acquisitions.
Operating income fell 43% to $621 millionb, from $1.088 billion, primarily because of a $596 million non-cash goodwill impairment charge at the Security Enterprise Solutions (SES) reporting unit, within the Civil segment, and $91 million of asset impairment charges. Net income attributable to common stockholders dropped to $199 million, or $1.44 diluted EPS, from $685 million and $4.96 a year earlier. The effective tax rate rose to 48.4% from 21.8%, mainly because the goodwill impairment is not tax deductible.
The company generated 87% of revenues from U.S. government contracts, and revenues under contracts with the DoD and U.S. Intelligence Community represented approximately 49% of total revenues. Funded backlog ended the year at $8.8 billionc, and total backlog reached $37.0 billion. Net bookings were $16.5 billion.
Operating cash flow rose to $1.165 billiond from $992 million, and cash and cash equivalents ended at $777 million. Total debt was $4.7 billion, and the company paid $201 million in dividends. Management flagged a $260 million increase in tax payments tied to the Tax Cuts and Jobs Act provision requiring amortization of R&D costs, and it expects a further increase of about $60 million in fiscal 2024.
The filing also discloses ongoing matters that investors should weigh. These include an internal investigation into international operations, self-reported to the Department of Justice and the SEC, a DOJ Antitrust Division grand jury subpoena, and uncertain proceeds from the VirnetX patent litigation. Beginning in fiscal 2024, Leidos will report four segments instead of three.
The company is also subject to ongoing DCAA audits and government contracting risks. Its stock is listed on the NYSE under the ticker LDOS.
02—Key points
Key Highlights
- Revenues rose 7% to $15.44 billion in fiscal 2023, supported by program wins, higher volumes on certain programs and business acquisitions.
- Operating income fell 43% to $621 million, from $1.088 billion, mainly due to a $596 million goodwill impairment at the SES reporting unit and $91 million in asset impairment charges.
- Diluted EPS was $1.44, compared with $4.96 in fiscal 2022. The effective tax rate increased to 48.4% from 21.8%, largely due to non-deductible goodwill impairments.
- Total backlog was $37.0 billion, including $8.8 billion of funded backlog. Net bookings were $16.5 billion, up from $15.4 billion.
- About 87% of revenues came from U.S. government contracts, and DoD and U.S. Intelligence Community work represented about 49% of total revenues.
- Operating cash flow increased to $1.165 billion from $992 million, while debt was $4.7 billion at year-end and quarterly dividends totaled $1.46 per share for the year.
- The filing discloses an ongoing internal investigation into international operations that has been self-reported to the DOJ and SEC, a DOJ Antitrust Division subpoena, and uncertain timing and amount of proceeds from the VirnetX litigation.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in FY2023, Leidos Holdings kept $0.01.
- Revenue$15.34B100.0%
- Cost of revenue−$13.19B86.0%
- Gross profit$2.15B14.0%
- Operating costs−$1.52B9.9%
- Operating income$621.0M4.0%
- Interest, other & tax−$422.0M2.8%
- Net income$199.0M1.3%
Where FY2023 revenue went
$15.34B- Cost of revenue: $13.19B, 86% of revenue
- Net income: $199.0M, 1.3% of revenue
- R&D: $128.0M, 0.8% of revenue
- SG&A: $942.0M, 6.1% of revenue
- Other operating costs: $454.0M, 3.0% of revenue
- Interest, other & tax: $422.0M, 2.8% of revenue
Kept 1.3% as net incomeNet income $199.0M · 1.3%R&D $128.0M · 0.8%
Full revenue history →04—Financials
Financial Highlights
Figures from 10-KFY2023filed February 13, 2024Financial Statements
FY2023 against FY2022
| Line item | FY2023FY2022 | Change |
|---|---|---|
| Revenue | $15.34B$14.29B | +7.4% |
| Cost of Revenue | $13.19B$12.31B | +7.2% |
| Gross Profit | $2.15B$1.98B | +8.6% |
| R&D Expenses | $128.00M$116.00M | +10.3% |
| SG&A Expenses | $942.00M$951.00M | −0.9% |
| Operating Income | $621.00M$1.09B | −42.9% |
| Net Income | $199.00M$693.00M | −71.3% |
| EPS (Basic) | $1.45$5.00 | −71.0% |
| EPS (Diluted) | $1.44$4.96 | −71.0% |
| Shares Outstanding (Basic) | 137.00M137.00M | 0.0% |
| Shares Outstanding (Diluted) | 138.00M138.00M | 0.0% |
05—Questions
Frequently Asked Questions
Why did Leidos's operating income decline so sharply in fiscal 2023?
Operating income fell $467 million, or 43%, to $621 million. The main driver was a $596 million non-cash goodwill impairment charge at the Security Enterprise Solutions reporting unit, which is part of the Civil segment. The company also recorded $91 million in asset impairment charges, including $79 million of intangible asset impairments tied to SES. The impairment followed strategic decisions to exit certain product offerings and cease operations in certain countries, along with delays in airline travel infrastructure projects.
How much of Leidos's revenue depends on the U.S. government?
Approximately 87% of fiscal 2023 revenues came from U.S. government contracts, either as a prime contractor or as a subcontractor. Revenues under contracts with the DoD and U.S. Intelligence Community represented about 49% of total revenues. The filing notes that budget uncertainty, continuing resolutions and possible government shutdowns could delay procurement and affect revenue.
What is the status of the internal investigation and government inquiries?
The company discovered activities in late 2021 by employees, third-party representatives and subcontractors connected to part of its international operations. An internal investigation overseen by an independent Board committee is ongoing, and Leidos has self-reported it to the DOJ and SEC. The company received a federal grand jury subpoena in September 2022 and cannot predict the timing or outcome. Separately, an August 2022 grand jury subpoena from the DOJ Antitrust Division relates to three U.S. government procurements, and the filing states it is not possible at this time to determine whether fines or other liabilities will be incurred.
How is Leidos's cash position and shareholder return?
Operating cash flow was $1.165 billion in fiscal 2023, up from $992 million, mainly due to faster collections and favorable timing of customer advance payments. That was partly offset by $260 million in higher tax payments tied to the TCJA R&D amortization provision. Cash and cash equivalents were $777 million at year-end, and debt was $4.7 billion. Dividends paid totaled $201 million, and open-market repurchases were $225 million during fiscal 2023.
What changes are coming to Leidos's reporting structure?
Beginning in fiscal 2024, Leidos will operate four reportable segments instead of three: National Security and Digital, Health & Civil, Commercial & International, and Defense Systems. Corporate costs will remain presented separately. Historical segment information will be recast to conform to the new structure beginning in the first quarter of fiscal 2024.
06—Continue